- Home
- About
- About NephU
- Meet The Team
- Supporting Organizations
- Community Advisors
- Contact Us
- Diversity, Equity, & Inclusion
- IgAN
- Expert Insights
- Mechanism of Disease
- Disease Burden & Progression
- Disease Management
- HCP/Patient Dialogue
- Events
- Resource Center
- Rare Kidney Diseases (PKD, IgAN, & Others)
- Kidney Disease & Mental Health
- Kidney Disease & Comorbid Conditions
- Transplantation & Dialysis
- NephU Nutrition & The NephChefR
- Radiology Toolkit
- On Demand Webinars
- Infographics
- Podcasts
- Videos
- Request a Presentation
- Simulators
What interests you?+Help Us Enhance Your NephU ExperienceHelp Us Enhance Your NephU Experience
User experience form
Archives

IgA Nephropathy: Pathogenesis, the Role of APRIL & the 4-Hit Process, & a Patient Case Study
About This Event
IgA Nephropathy: Pathogenesis, the Role of APRIL & the 4-Hit Process, & a Patient Case Study
IgA Nephropathy: Pathogenesis, the Role of APRIL and the 4-Hit Process, and a Patient Case Study – Dr. Biruh Workeneh
-
- Program Objectives:
- The disease burden and current treatment landscape in IgA Nephropathy
- Risk factors associated with disease progression in a patient case study
- The four-hit process in IgA nephropathy pathogenesis and the role of APRIL
- Program Objectives:
IgAN Simulator – Josh Gariboldi, PharmD, BCPS
-
- Here you can get an in-depth look at IgAN pathogenesis and the journeys of patients living with IgAN
- Pathogenesis: See the origins of IgAN at the molecular level and how that result sin its progression
- Progression: Journey into the profiles of 3 hypothetical patients to see how their IgAN diagnosis was uncovered, and what’s expected in their prognosis
- Here you can get an in-depth look at IgAN pathogenesis and the journeys of patients living with IgAN
Apple Vision Pro Immersive Experience – Michael Filsinger and Geoff Lockwood
-
- Experience disease state education like never before. Using Apple Vision Pro technology, participants can visually explore:
- The 4-hit pathogenic progress of IgAN
- The role of APRIL in initiating and sustaining kidney injury in IgAN
- Experience disease state education like never before. Using Apple Vision Pro technology, participants can visually explore:
NephU Resource Station – Michael Filsinger and Geoff Lockwood
-
- Check out our educational infographics and grab printed copies to take with you
- Learn about our educational tools and treatment summaries
Location
Ruth’s Chris Steak House
Featuring
Biruh Workeneh, MD, FASN
Provider, Professor in the Section of Nephrology, MD Anderson Internal Medicine CenterMD Anderson Internal Medicine Center*
Dr. Biruh Workeneh is a provider in the MD Anderson Internal Medicine Center and a Professor in the Section of Nephrology. He is board-certified in Internal Medicine and joined MD Anderson in 2015. Dr. Workeneh graduated from medical school at the University of Texas McGovern Medical School and completed a clinical nephrology and post-doctorate fellowship at Stanford University. He has received numerous nephrology, teaching, and research awards, served as primary investigator in multiple clinical trials, and has been the author of many publications.
Josh Gariboldi, PharmD, BCPS
Nephrology Senior Medical Science LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Josh Gariboldi, PharmD, BCPS joined Otsuka in January 2021 and is a Senior Medical Science Liaison on our Nephrology East Team, covering the Carolinas and Tennessee. Dr Gariboldi earned his Doctor of Pharmacy degree from the University of Florida in 2012. He has more than eight years of experience as a clinical pharmacist in both the community and hospital settings, most recently at Bon Secours Mercy Health St. Francis Hospital in Greenville, SC. Dr Gariboldi served as a preceptor with Presbyterian College School of Pharmacy, where he instructed students on Advanced Pharmacy Practice rotations. He holds board certifications in both pharmacotherapy and medical affairs.
Michael Filsinger, MPA, PA-C
Nephrology Medical Science LiaisonOtsuka Pharmaceutical Development & Commercialization, Inc.*
Michael Filsinger, MPA, PA-C is a Medical Science Liaison at Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Michael earned his Bachelor of Health Care Sciences as well as Master of Physician Assistant at Duquesne University in Pittsburgh, PA. Following his graduate training, Michael went on to complete a Pediatric Surgery Residency at Children’s National Medical Center in Washington, DC Prior to joining Otsuka, Michael spent the last 15 years working in solid organ transplant in Charlotte, NC where he developed a passion for improving the care of patients with renal disease and ESKD.
Geoffrey Lockwood, PharmD, BCPS, MBA
Nephrology Medical Science DirectorOtsuka Pharmaceutical Development & Commercialization, Inc.*
Geoffrey Lockwood, PharmD, BCPS, MBA is a clinical pharmacist who works as a Senior Medical Science Liaison with Otsuka Pharmaceutical Development & Commercialization, Inc. He has been in his current role for 2 years, supporting Nephrology. Prior to joining Otsuka, he worked as an Emergency Medicine and Critical Care Clinical Pharmacist at Spectrum Health Butterworth Hospital in Grand Rapids, Michigan. Dr Lockwood earned his Doctor of Pharmacy Degree from Ferris State University in Big Rapids, Michigan. Dr Lockwood completed a PGY-1 Pharmacy Practice Residency with Christus Spohn Health System in Corpus Christi, Texas. Upon completion of residency, Dr. Lockwood worked as a Critical Care Clinical Pharmacy Specialist with Christus Spohn Memorial Hospital in Corpus Christi, Texas. He then moved to South Bend, Indiana where he took on the role of Clinical Pharmacy and Pharmacy Residency Program Coordinator at Memorial Hospital of South Bend. Dr Lockwood then moved to Elkhart General Hospital where he started the Emergency Medicine Clinical Pharmacy Program and served as an Emergency Medicine Clinical Pharmacy Specialist. Dr Lockwood is currently working to complete his MBA with a Value-Driven Organization emphasis through Central Michigan University. Dr Lockwood is board certified in pharmacotherapy and is a licensed pharmacist in the states of Michigan and Indiana.
Biruh Workeneh, MD, FASN is a speaker for Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Josh Gariboldi, PharmD, BCPS, Michael Filsinger, MPA, PA-C, and Geoffrey Lockwood, PharmD, BCPS, MBA are employees of Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC)
Registration
Join Today for Instant Access to all NephU Offerings.
Membership is free!
Join NephU today at no cost to register for this event and access to other premium content.
- The NephU Community is collaborating to improve care and the future outcomes for individuals with kidney disease and other related conditions.
- Quickly learn more about the topics that interest you.
- Access our library of on-demand kidney health resources
- Gain key insights from industry experts & though leaders.
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the kidney health community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.©2025 Otsuka Pharmaceutical Development & Commercialization, Inc. All rights reserved.